Dr. McGregor on unmet needs in metastatic renal cell carcinoma

Video

Bradley McGregor, MD, explains how despite major advances in metastatic renal cell carcinoma, there are still patients who do not respond or maintain their initial response to the novel treatment option. Therefore, McGregor, says there remains a need for novel treatment targets and therapies in this space. McGregor is clinical director, Lank Center for Genitourinary Oncology, senior physician, instructor in Medicine, Harvard Medical School, Dana-Farber Cancer Institute.

Related Videos
Nirmish Singla, MD, MSc, answers a question during a Zoom video interview
Human kidney cross section on scientific background | Image Credit: © Crystal light - stock.adobe.com
Nirmish Singla, MD, MSc, answers a question during a Zoom video interview
Carlos Muñoz-Lopez and Dr. Steven Campbell in an interview with Urology Times
Carlos Muñoz-Lopez and Dr. Steven Campbell in an interview with Urology Times
Dr. Michael Stifelman in an interview with Urology Times
Teona Iarajuli in an interview with Urology Times
hospital corridor
Related Content
© 2023 MJH Life Sciences

All rights reserved.